Elanco Animal Health Inc (NYSE:ELAN) shares traded 26.29% higher at $12.01 on Wall Street last session.
ELAN stock price is now 20.34% away from the 50-day moving average and -2.36% away from the 200-day moving average. The market capitalization of the company currently stands at $5.96B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $18, UBS recently initiated with Buy rating for Elanco Animal Health Inc (NYSE: ELAN). On December 02, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $14, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Kurzius Lawrence Erik, Director bought 10,000 shares of the company’s stock on Mar 07 ’25. The stock was bought for $109,000 at an average price of $10.90. Upon completion of the transaction, the Director now directly owns 101,459 shares in the company, valued at $1.22 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 11 ’25, Director Kurzius Lawrence Erik bought 10,000 shares of the business’s stock. A total of $102,000 was incurred on buying the stock at an average price of $10.20. This leaves the insider owning 111,459 shares of the company worth $1.34 million. A total of 0.95% of the company’s stock is owned by insiders.
During the past 12 months, Elanco Animal Health Inc has had a low of $8.02 and a high of $18.80. As of last week, the company has a debt-to-equity ratio of 0.73, a current ratio of 2.44, and a quick ratio of 1.25.
The net profit margin was 7.61% and return on equity was 5.49% for ELAN. The company reported revenue of $1.02 billion for the quarter, compared to $1.03 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.45 percent. For the current quarter, analysts expect ELAN to generate $1.18B in revenue.
